Tumor
164
30
40
67
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
14 trials with published results (9%)
Research Maturity
67 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.1%
10 terminated out of 164 trials
87.0%
+0.5% vs benchmark
5%
9 trials in Phase 3/4
21%
14 of 67 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 67 completed trials
Clinical Trials (164)
SBRT-LATTICE-PATHY
Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT
Collection of Blood and Urine From Patients Undergoing Radiation Therapy
A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
A Study of Live Tumor Fragments of Surgical Resections
68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
Evaluation of Proton Therapy in Pediatric Cancer Patients
The Needs and Burden of Family Caregivers of Older Adults With Cancer
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures
Prospective Use of Philips iSuite for Interventional Procedures
T Cell Receptor Gene-Engineered and Dominant Negative TGF-β Receptor T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases